Skip to main content

Table 65 (abstract A676). Antibiotics usage

From: ESICM LIVES 2016: part two

Antibiotic

VAC (n=82)

IVAC (n=38)

PVAP (n=32)

VAE (n=152)

Non-VAE (n=706)

PCN

44 (53.7%)

22 (57.9%)

24 (75.0%)

90 (59.2%)

306 (43.3%)

Cephalosporin

52 (63.4%)

21 (55.3%)

23 (71.9%)

96 (63.2%)

364 (51.6%)

Vancomycin

66 (80.5%)

36 (94.7%)

26 (81.3%)

128 (84.2%)

441 (62.5%)

Macrolides

19 (23.2%)

6 (15.8%)

4 (12.5%)

29 (19.1%)

83 (11.8%)

Quinolones

31 (37.8%)

16 (42.1%)

17 (53.1%)

64 (42.1%)

172 (24.4%)

Carbapenems

40 (48.8%)

17 (44.7%)

16 (50.0%)

73 (48%)

99 (14.0%)

Metronidazole

37 (45.1%)

19 (50.0%)

17 (53.1%)

73 (48%)

147 (20.8%)